Table 1. Characteristics of the Two... | American Society of Hematology

Table 1.

Characteristics of the Two Cohorts of LT-NP (ALT) and Standard Progressors (IMMUNOCO) at Inclusion

	ALT (LT-NPs) n = 70	IMMUNOCO (progressors) n = 83	P Value^*
Cohort started	1996	1991-1992
Inclusion criteria	18 yr of age or more	18 yr of age or more
	and
	Time since first HIV⁺ test equal to or above 8 yr	Any time
	and
	No AIDS symptoms (stage A)	Any stage
	and
	No antiviral treatment	With or without antiviral treatment
	and	and
	CD4 counts >600/μL during last 5 yr	CD4 counts >150/μL at entry
Sex (% men)	53 (76%)	67 (81%)	.453
Time since first HIV⁺test (yr)^†	9.7 (7.8-12.4)	4.3 (0.2-9.1)	<.001
Age at first HIV⁺ test (yr)^†	27.8 (12.2-56.1)	29.7 (18.6-49.2)	.096
Transmission group
Homosexual/bisexual men	37 (53%)	56 (67%)	.181
Heterosexuals	6 (9%)	8 (10%)
IV drug users	16 (23%)	13 (16%)
Others	11 (15%)	6 (7%)
No. of CD4 cells/μL^†	672 (278-1,286)	361 (115-1,331)	<.001
No. of CD8 cells/μL^†	955 (391-2,265)	949 (242-2,534)	.502

	ALT (LT-NPs) n = 70	IMMUNOCO (progressors) n = 83	P Value^*
Cohort started	1996	1991-1992
Inclusion criteria	18 yr of age or more	18 yr of age or more
	and
	Time since first HIV⁺ test equal to or above 8 yr	Any time
	and
	No AIDS symptoms (stage A)	Any stage
	and
	No antiviral treatment	With or without antiviral treatment
	and	and
	CD4 counts >600/μL during last 5 yr	CD4 counts >150/μL at entry
Sex (% men)	53 (76%)	67 (81%)	.453
Time since first HIV⁺test (yr)^†	9.7 (7.8-12.4)	4.3 (0.2-9.1)	<.001
Age at first HIV⁺ test (yr)^†	27.8 (12.2-56.1)	29.7 (18.6-49.2)	.096
Transmission group
Homosexual/bisexual men	37 (53%)	56 (67%)	.181
Heterosexuals	6 (9%)	8 (10%)
IV drug users	16 (23%)	13 (16%)
Others	11 (15%)	6 (7%)
No. of CD4 cells/μL^†	672 (278-1,286)	361 (115-1,331)	<.001
No. of CD8 cells/μL^†	955 (391-2,265)	949 (242-2,534)	.502

P values were computed using Mann-Whitney and the χ² tests.

†

All CD4 and CD8 cell measures were performed in our laboratory; data is presented as median values with, in parentheses, the minimum-maximum values. All participants of both cohorts gave consent for the studies.

View Large

This Feature Is Available To Subscribers Only